Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry
Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry
Introduction: sarcoidosis is a multi-system granulomatous disease, with significant heterogeneity in many aspects of the disease. We reviewed 10y database from the British Thoracic Society UK ILD Registry and present salient findings on demographics, management and clinical symptoms.
Methods: participating centres entered data onto a central electronic database between 1 January 2013 and 19 February 2023. Informed consent was obtained by all participants. A cross-sectional descriptive analysis was undertaken.
Results: data were available from 937 unique cases from 50 centres. There was a male preponderance (60%); mean age 52.7y (± 26.9). The cohort was predominantly white (65%). Black patients formed 7% of the cohort compared to 3% of the national population of the UK. Systemic hypertension affected 21% of patients, and diabetes 16%, while almost two thirds had no reported comorbidities. Over 10 years, the proportion of cases where at least one biopsy was obtained remained largely consistent (93%); and during that time the use of endobronchial ultrasound (EBUS) rose from 38% to 64%. Less than half of patients experienced breathlessness and cough (45% and 41%) and 26% experienced fatigue, which can impact daily activities. At presentation 46% of patients were prescribed systemic corticosteroids; 42% were not treated, 1 in 4 patients was referred or signposted to other support (such as patient support groups or mental health support) and 2% were in clinical trials.
Conclusion: these data provide a snapshot of clinical practice across ILD centres in the UK over the last decade which could be used as a basis for further work in improving the management of patients with sarcoidosis.
Ho, Ling-Pei
aebaf5ec-4708-4e4f-a83c-e5302ae7bce5
Loughenbury, Maria
9c30cb11-662b-42b5-8fa4-88c6027d79a8
Casimo, Leo
e888f46a-b7ec-44b9-b370-24bf9469a56b
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe
30 October 2024
Ho, Ling-Pei
aebaf5ec-4708-4e4f-a83c-e5302ae7bce5
Loughenbury, Maria
9c30cb11-662b-42b5-8fa4-88c6027d79a8
Casimo, Leo
e888f46a-b7ec-44b9-b370-24bf9469a56b
Fletcher, Sophie
71599088-9df7-4d4a-8570-aef773ead0fe
Ho, Ling-Pei, Loughenbury, Maria and Casimo, Leo
,
et al.
(2024)
Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry.
European Respiratory Journal, 64.
(doi:10.1183/13993003.congress-2024.OA954).
Record type:
Meeting abstract
Abstract
Introduction: sarcoidosis is a multi-system granulomatous disease, with significant heterogeneity in many aspects of the disease. We reviewed 10y database from the British Thoracic Society UK ILD Registry and present salient findings on demographics, management and clinical symptoms.
Methods: participating centres entered data onto a central electronic database between 1 January 2013 and 19 February 2023. Informed consent was obtained by all participants. A cross-sectional descriptive analysis was undertaken.
Results: data were available from 937 unique cases from 50 centres. There was a male preponderance (60%); mean age 52.7y (± 26.9). The cohort was predominantly white (65%). Black patients formed 7% of the cohort compared to 3% of the national population of the UK. Systemic hypertension affected 21% of patients, and diabetes 16%, while almost two thirds had no reported comorbidities. Over 10 years, the proportion of cases where at least one biopsy was obtained remained largely consistent (93%); and during that time the use of endobronchial ultrasound (EBUS) rose from 38% to 64%. Less than half of patients experienced breathlessness and cough (45% and 41%) and 26% experienced fatigue, which can impact daily activities. At presentation 46% of patients were prescribed systemic corticosteroids; 42% were not treated, 1 in 4 patients was referred or signposted to other support (such as patient support groups or mental health support) and 2% were in clinical trials.
Conclusion: these data provide a snapshot of clinical practice across ILD centres in the UK over the last decade which could be used as a basis for further work in improving the management of patients with sarcoidosis.
This record has no associated files available for download.
More information
e-pub ahead of print date: 30 October 2024
Published date: 30 October 2024
Identifiers
Local EPrints ID: 504224
URI: http://eprints.soton.ac.uk/id/eprint/504224
ISSN: 0903-1936
PURE UUID: 3aafb40c-a53f-4d1e-9d45-547b99dfe613
Catalogue record
Date deposited: 01 Sep 2025 16:35
Last modified: 06 Sep 2025 02:18
Export record
Altmetrics
Contributors
Author:
Ling-Pei Ho
Author:
Maria Loughenbury
Author:
Leo Casimo
Author:
Sophie Fletcher
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics